1899-24-7 | 5-Bromofuran-2-carbaldehyde

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$15.00	$10.00
1g	98%	in stock	$18.00	$12.00
10g	98%	in stock	$20.00	$14.00
25g	98%	in stock	$39.00	$27.00
500g	98%	in stock	$713.00	$499.00

Description

• Catalog Number: AB11402
• Chemical Name: 5-Bromofuran-2-carbaldehyde
• CAS Number: 1899-24-7
• Molecular Formula: C5H3BrO2
• Molecular Weight: 174.9801
• MDL Number: MFCD00159501
• SMILES: Brc1ccc(o1)C=O

Computed Properties

• Complexity: 94.4
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 1
• XLogP3: 1.8

Upstream Synthesis Route

5-Bromo-2-furaldehyde, also known as $(name)$, serves as a versatile building block in chemical synthesis due to its unique properties and reactivity. This compound plays a vital role in the development of various organic compounds and pharmaceuticals.In chemical synthesis, 5-Bromo-2-furaldehyde is commonly used as a key intermediate in the production of heterocyclic compounds. Its aromatic furan ring provides a stable framework for further modifications, allowing for the incorporation of different functional groups and substitutions. This versatility makes it a valuable starting material for the synthesis of a wide range of complex molecules.Furthermore, the bromine substituent on the furan ring of 5-Bromo-2-furaldehyde offers opportunities for diverse synthetic transformations, such as nucleophilic substitution, palladium-catalyzed coupling reactions, and oxidative transformations. These reactions enable chemists to tailor the structure and properties of the resulting compounds for specific applications in drug discovery, agrochemicals, materials science, and other fields.Overall, the strategic application of 5-Bromo-2-furaldehyde in chemical synthesis showcases its significance as a crucial building block for the design and preparation of novel compounds with diverse functionalities and applications.

Literature

• Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.

  Gastroenterology 20170401

• A novel HLA-A*3315 allele identified by haplotype-specific extraction and sequence-based typing.

  Tissue antigens 20080701

• Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051001